INS and type 2 diabetes mellitus: Later, ceramide levels in body tissue and plasma were correlated with diminished insulin sensitivity among obese and type 2 diabetic patients [10, 11]; and in 2007, increased endogenous ceramide synthesis came into the spotlight as to cause insulin resistance in vivo [12].